>

>

Technology prioritization for stem cell (iPSC) regenerative medicine technology

Service Areas
Therapeutic Areas

Oncology

Client Type

Pre-clinical client

Client Problems

  • A venture capital firm wanted to understand the landscape of a new stem cell platform technology for use in the regenerative medicine field


  • They wanted to comprehend the technical advantages, stage of development, therapeutic uses, technical feasibility and intellectual property surrounding the technology.

What We Did

  • Identified companies using the novel platform technology and performed technical due diligence on each of the technologies.


  • We compared the technologies based on their approaches, merits, and stage of development


  • Compared the companies, the indications pursued, stage of development, partnerships, licensing and IP analysis.


  • Performed a deep dive on each company

Our Results And Insight

  • Technology comparison


  • Company comparison


  • Technical due diligence for one of the identified technologies


  • Company deep dive

See other case studies

Commercial Strategy case studies >

Oncology case studies >

Service Areas Details

Commercial Strategy (Technical Assessment)

Therapeutic Areas Details

Oncology (Stem Cell)

© 2019, First Principles Advisory Group. All Rights Reserved
SF Bay Area, Denver, Seattle, New York City, Cambridge
First Principles Advisory Group
1290 Howard Street Suite 323
Burlingame, CA 94010
(415) 669-5183
info@fpadvisory.net